Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
    Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date:  SAPPHIRE: Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs (clinicaltrials.gov) -  Jan 11, 2023   
    P2/3,  N=12, Active, not recruiting, 
    Trial completion date: Dec 2023 --> Dec 2033 Recruiting --> Active, not recruiting | N=45 --> 12 | Trial completion date: Dec 2025 --> Dec 2023 | Trial primary completion date: Dec 2025 --> Dec 2023
  • ||||||||||  Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
    Trial completion date, Trial primary completion date:  SAPPHIRE: Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs (clinicaltrials.gov) -  May 3, 2022   
    P2/3,  N=45, Recruiting, 
    Recruiting --> Active, not recruiting | N=45 --> 12 | Trial completion date: Dec 2025 --> Dec 2023 | Trial primary completion date: Dec 2025 --> Dec 2023 Trial completion date: Dec 2023 --> Dec 2025 | Trial primary completion date: Dec 2023 --> Dec 2025
  • ||||||||||  Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
    Trial completion date:  ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) -  Dec 2, 2020   
    P2b,  N=47, Active, not recruiting, 
    Trial completion date: Apr 2021 --> Dec 2023 | Trial primary completion date: Oct 2020 --> Dec 2023 Trial completion date: Mar 2030 --> Sep 2030
  • ||||||||||  Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
    Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date:  ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) -  Nov 26, 2019   
    P2b,  N=47, Active, not recruiting, 
    Trial completion date: Mar 2030 --> Sep 2030 Recruiting --> Active, not recruiting | N=100 --> 47 | Trial completion date: Dec 2019 --> Mar 2030 | Trial primary completion date: Dec 2018 --> Mar 2020
  • ||||||||||  Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
    Trial completion date, Trial primary completion date:  ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) -  Feb 7, 2018   
    P2b,  N=100, Recruiting, 
    Recruiting --> Active, not recruiting | N=100 --> 47 | Trial completion date: Dec 2019 --> Mar 2030 | Trial primary completion date: Dec 2018 --> Mar 2020 Trial primary completion date: Dec 2016 --> Dec 2018 | Trial completion date: Dec 2016 --> Dec 2019
  • ||||||||||  Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
    Trial initiation date:  ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) -  Aug 1, 2013   
    P2b,  N=100, Recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Apr 2017 --> Sep 2017 Initiation date: Apr 2013 --> Jul 2013
  • ||||||||||  Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
    Enrollment open:  ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) -  Aug 1, 2013   
    P2b,  N=100, Recruiting, 
    Initiation date: Apr 2013 --> Jul 2013 Not yet recruiting --> Recruiting